Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights.
about
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesA simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestineNovel preparation of PLGA/HP55 nanoparticles for oral insulin delivery.Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?Microencapsulation techniques to develop formulations of insulin for oral delivery: a review.Oral insulin delivery systems using chitosan-based formulation: a review.pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria.Novel PEG-graft-PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium.Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery.Buccal adhesive nanofibers containing human growth hormone for oral mucositis.Microencapsulation of insulin using a W/O/W double emulsion followed by complex coacervation to provide protection in the gastrointestinal tract.Chitosan-based Polyelectrolyte Complexes: Characteristics and Application in Formulation of Particulate Drug CarrierspH-sensitive polyelectrolyte films derived from submicron chitosan/Eudragit®L 100-55 complexes: Physicochemical characterization andin vitrodrug releaseUltrasonic atomization and polyelectrolyte complexation to produce gastroresistant shell-core microparticlesPrerequisite Characteristics of Nanocarriers Favoring Oral Insulin Delivery: Nanogels as an Opportunity
P2860
Q26779447-BB83D324-E332-43E5-9BFE-8579E64914F8Q35864826-6861A691-D46B-4192-9F1F-C702224F44CDQ36218161-1070C1B5-A900-4B9A-86E7-3578E0C2F820Q38024311-43C94986-3855-4F9A-8C6C-DD1B92E7E7D1Q38066966-B5D43659-1DC6-40D5-A5A4-E9B9B0E19BB1Q38628388-BC92A702-0ADB-4FDF-8AE9-6F55CAB7B7A4Q38757836-C0D10E70-BCBA-4C89-82CF-4A5A77640D57Q38880439-BC1455D8-7318-4E8E-8188-DDD7FA169C1EQ39182355-46354DBB-1E63-4F1B-B362-6CB7D69E6ED8Q41822902-C41BCE87-F3AD-4B34-9CA0-692A826CCB01Q42031220-105FAEA0-7612-4D78-BD0D-1AD82CF060DFQ51750508-C5194466-05F4-44FF-8B45-9DF0DA38060FQ51827636-087FDAAC-89B1-4E74-AFD8-9AA381A2778CQ53582565-7F4151F8-8E6B-45DC-83A2-17405A838EF2Q57341143-DEB7BFC9-A19C-40BF-9F99-55D0B4E28D2FQ57342180-1E40AEE3-2EFC-41FC-B2F4-AD1D658FF54CQ57342372-1838A0C7-4E88-42F7-931F-4CC63D6AE376Q57348419-210F3F9A-B7E5-48B5-BF2E-B5C661EE0475
P2860
Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of pH-sensitive in ...... h different molecular weights.
@en
type
label
Development of pH-sensitive in ...... h different molecular weights.
@en
prefLabel
Development of pH-sensitive in ...... h different molecular weights.
@en
P2093
P2860
P1433
P1476
Development of pH-sensitive in ...... th different molecular weights
@en
P2093
Badir Delf Loveymi
Hadi Valizadeh
Mohammad Reza Siahi-Shadbad
Parvin Zakeri-Milani
Zahra Azari
P2860
P2888
P304
P356
10.1208/S12249-010-9488-7
P407
P577
2010-08-05T00:00:00Z
P5875
P6179
1004454448